Upadacitinib Tops Abatacept for RA Refractory to DMARDs
Superior for mean change in composite DAS28-CRP values and remission, but more adverse events seen
Pharmacotherapy, Psychotherapy Combo Best for Bipolar Disorder
Manualized treatments linked to significantly reduced recurrence rates versus control treatments
Outcomes Worse for Women With MI at 50 Years or Younger
Women less likely to undergo coronary revascularization, receive guideline-directed medical treatment
FDA Requiring Labeling Changes to NSAIDs Warning of Risks in Pregnancy
Labeling must indicate risks to unborn baby with NSAID use at 20 weeks of pregnancy or later
Use of Common Meds Tied to Lower Lung Cancer Mortality
Combined use of aspirin, statins, metformin tied to lower lung cancer risk and mortality
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...
Ertugliflozin Noninferior for CV Outcomes in T2DM With ASCVD
Ertugliflozin is noninferior to placebo for the primary end point of major adverse cardiovascular events
Cannabinoid Use Tied to Adverse Outcomes With COPD
In older adults with COPD, cannabinoid use tied to all-cause mortality, hospitalizations
Polypharmacy Common in Seniors With Heart Failure
With increasing number of medications, more rapid increase seen in number of noncardiovascular meds
COVID-19 Antibody Treatment Study Paused
ACTIV-3 study, testing use of an antibody therapy with remdesivir, paused 'out of an abundance of caution'
